We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Compared to Estimates, Waters (WAT) Q3 Earnings: A Look at Key Metrics
Read MoreHide Full Article
Waters (WAT - Free Report) reported $711.69 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 0.4%. EPS of $2.84 for the same period compares to $2.64 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $724.83 million, representing a surprise of -1.81%. The company delivered an EPS surprise of +10.94%, with the consensus EPS estimate being $2.56.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Waters performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales- Water Division: $629.35 million compared to the $634.58 million average estimate based on three analysts. The reported number represents a change of +1% year over year.
Net Sales- TA Division: $82.34 million versus the three-analyst average estimate of $87.62 million. The reported number represents a year-over-year change of -3.3%.
Net Sales-Markets-Academic & Government: $80.71 million versus the two-analyst average estimate of $85.97 million.
Service net sales- TA service: $25.06 million versus $22.75 million estimated by two analysts on average.
Service sales: $263.61 million versus the two-analyst average estimate of $246.98 million.
Product Net Sales- Waters instrument systems: $262.14 million versus the two-analyst average estimate of $281.46 million.
Product Net Sales- Chemistry consumables: $128.65 million versus $131.39 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.4% change.
Product Net Sales- TA instrument systems: $57.29 million versus $63.54 million estimated by two analysts on average.
Service net sales- Waters service: $238.56 million versus $224.24 million estimated by two analysts on average.
Net sales-Markets-Industrial: $209.45 million versus the two-analyst average estimate of $227.90 million.
Net Sales-Markets-Pharmaceutical: $421.54 million versus the two-analyst average estimate of $410.69 million.
Product sales: $448.08 million compared to the $476.38 million average estimate based on two analysts.
Shares of Waters have returned -3% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Compared to Estimates, Waters (WAT) Q3 Earnings: A Look at Key Metrics
Waters (WAT - Free Report) reported $711.69 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 0.4%. EPS of $2.84 for the same period compares to $2.64 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $724.83 million, representing a surprise of -1.81%. The company delivered an EPS surprise of +10.94%, with the consensus EPS estimate being $2.56.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Waters performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Water Division: $629.35 million compared to the $634.58 million average estimate based on three analysts. The reported number represents a change of +1% year over year.
- Net Sales- TA Division: $82.34 million versus the three-analyst average estimate of $87.62 million. The reported number represents a year-over-year change of -3.3%.
- Net Sales-Markets-Academic & Government: $80.71 million versus the two-analyst average estimate of $85.97 million.
- Service net sales- TA service: $25.06 million versus $22.75 million estimated by two analysts on average.
- Service sales: $263.61 million versus the two-analyst average estimate of $246.98 million.
- Product Net Sales- Waters instrument systems: $262.14 million versus the two-analyst average estimate of $281.46 million.
- Product Net Sales- Chemistry consumables: $128.65 million versus $131.39 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.4% change.
- Product Net Sales- TA instrument systems: $57.29 million versus $63.54 million estimated by two analysts on average.
- Service net sales- Waters service: $238.56 million versus $224.24 million estimated by two analysts on average.
- Net sales-Markets-Industrial: $209.45 million versus the two-analyst average estimate of $227.90 million.
- Net Sales-Markets-Pharmaceutical: $421.54 million versus the two-analyst average estimate of $410.69 million.
- Product sales: $448.08 million compared to the $476.38 million average estimate based on two analysts.
View all Key Company Metrics for Waters here>>>Shares of Waters have returned -3% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.